Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort studyXiaocong Li Marston, Martin Unverdorben, X. Ye et al.|International Journal of Cardiology|2021Cited by 35
Comparison of clinical outcomes with edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonist in patients with atrial fibrillation in Germany: a real-world cohort studyXiaocong Li Marston, Martin Unverdorben, R Wang et al.|European Heart Journal|2020Cited by 4